Alendronate Sodium
- Product NDC
- 61919-729
- 11-digit product format
- 619190729
- Labeler code
- 61919
- Product ID
- 61919-729_7fbca6be-aab0-19d4-e053-2991aa0a72eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alendronate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076768
- Marketing category
- ANDA
- Marketing start
- 2019-01-18
- Marketing end
- 0000-00-00
- Substance
- ALENDRONATE SODIUM
- Active strength
- 35 mg/1
- Pharmacologic classes
- Bisphosphonate [EPC],Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-729-04 | Alendronate Sodium | 4 in 1 BOTTLE | TABLET | 4 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-729 | ALENDRONATE SODIUM TABLET [DIRECT_RX] | 1 | Legacy NDC, 1 package rows | 20190119_7fbca6be-aaaf-19d4-e053-2991aa0a72eb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-729-04 | 61919072904 | 4 TABLET in 1 BOTTLE (61919-729-04) | 4 tablet | 2019-01-18 | 0000-00-00 | No | No | Current |